Investors seek safety in a stable pharma amid recession fears

Stocks such as Divi’s Laboratories, Ipca, Dr Reddy’s, Cipla, and Alkem Laboratories have gained between 2% and 4% in the past week. The sector was in a consolidation phase in the past year due to a decline in business growth post-Covid, and valuations dropped about a fifth.

More To Explore